Hear CEO Mari Anne Snow describe the advantages she sees nanoparticles having over current modalities like viral vectors, LNPs, and others.

Apr 04, 2025

State of Possible: Winner of the MassBioDrive Startup of the Year Award last year, the Co-Founder and CEO of Eascra Biotech describes developing nanoparticles as a delivery vehicle for therapies

Posted by Eascra Biotech